对于妊娠期妇女的治疗，我们认为应该选用有良好安全性参数的药物尽量在孕期持续进行治疗，而不应该推迟治疗。
In terms of the treatment of women during pregnancy, we believe that providing the drugs used have a good safety parameter, we should try to continue treatment through the pregnancy and not defer.
妊娠期孕妇有着特殊的生理和药代动力学变化，妊娠期心律失常药物治疗有其特殊性和重要性，故临床用药应顾及胎儿安全。
There are some particularity and importance for antiarrhythmic pharmacotherapy in pregnancy. More attention should be paid to safety of fetus in clinical pharmacotherapy.
妊娠期孕妇有着特殊的生理和药代动力学变化，妊娠期心律失常药物治疗有其特殊性和重要性，故临床用药应顾及胎儿安全。
There are some particularity and importance for antiarrhythmic pharmacotherapy in pregnancy. More attention should be paid to safety of fetus in clinical pharmacotherapy.
应用推荐